Levine MM - Search Results

1

An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution.

Waddington CS, Darton TC, Jones C, Haworth K, Peters A, John T, Thompson BA, Kerridge SA, Kingsley RA, Zhou L, Holt KE, Yu LM, Lockhart S, Farrar JJ, Sztein MB, Dougan G, Angus B, Levine MM, Pollard AJ. Waddington CS, et al. Among authors: levine mm. Clin Infect Dis. 2014 May;58(9):1230-40. doi: 10.1093/cid/ciu078. Epub 2014 Feb 10. Clin Infect Dis. 2014. PMID: 24519873 Free PMC article.

2

Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine.

Chatfield SN, Fairweather N, Charles I, Pickard D, Levine M, Hone D, Posada M, Strugnell RA, Dougan G. Chatfield SN, et al. Vaccine. 1992;10(1):53-60. doi: 10.1016/0264-410x(92)90420-o. Vaccine. 1992. PMID: 1311488

3

Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge.

Harpaz R, Edelman R, Wasserman SS, Levine MM, Davis JR, Sztein MB. Harpaz R, et al. Among authors: levine mm. J Clin Invest. 1992 Aug;90(2):515-23. doi: 10.1172/JCI115889. J Clin Invest. 1992. PMID: 1644922 Free PMC article.

4

Construction of genetically defined double aro mutants of Salmonella typhi.

Hone DM, Harris AM, Chatfield S, Dougan G, Levine MM. Hone DM, et al. Among authors: levine mm. Vaccine. 1991 Nov;9(11):810-6. doi: 10.1016/0264-410x(91)90218-u. Vaccine. 1991. PMID: 1759503

5

Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studies.

Tacket CO, Losonsky G, Taylor DN, Baron LS, Kopecko D, Cryz S, Levine MM. Tacket CO, et al. Among authors: levine mm. J Infect Dis. 1991 Apr;163(4):901-4. doi: 10.1093/infdis/163.4.901. J Infect Dis. 1991. PMID: 2010645

6

Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee.

Black RE, Levine MM, Ferreccio C, Clements ML, Lanata C, Rooney J, Germanier R. Black RE, et al. Among authors: levine mm. Vaccine. 1990 Feb;8(1):81-4. doi: 10.1016/0264-410x(90)90183-m. Vaccine. 1990. PMID: 2180234 Clinical Trial.

7

Challenge studies in volunteers using Escherichia coli strains with diffuse adherence to HEp-2 cells.

Tacket CO, Moseley SL, Kay B, Losonsky G, Levine MM. Tacket CO, et al. Among authors: levine mm. J Infect Dis. 1990 Aug;162(2):550-2. doi: 10.1093/infdis/162.2.550. J Infect Dis. 1990. PMID: 2197345 Clinical Trial.

8

Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine.

Black RE, Levine MM, Clements ML, Losonsky G, Herrington D, Berman S, Formal SB. Black RE, et al. Among authors: levine mm. J Infect Dis. 1987 Jun;155(6):1260-5. doi: 10.1093/infdis/155.6.1260. J Infect Dis. 1987. PMID: 2437220

9

Progress in vaccines against typhoid fever.

Levine MM, Ferreccio C, Black RE, Tacket CO, Germanier R. Levine MM, et al. Rev Infect Dis. 1989 May-Jun;11 Suppl 3:S552-67. doi: 10.1093/clinids/11.supplement_3.s552. Rev Infect Dis. 1989. PMID: 2669099 Review.

10

Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans.

Sztein MB, Tanner MK, Polotsky Y, Orenstein JM, Levine MM. Sztein MB, et al. Among authors: levine mm. J Immunol. 1995 Oct 15;155(8):3987-93. J Immunol. 1995. PMID: 7561107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

727 results

Search Page